nach oben

Journal of Neuro-Oncology

Erschienen in:

13.05.2019 | Clinical Study

Comparative analysis of intracranial meningiomas in patients younger than 40 years

verfasst von: Tianhao Hu, Run Wang, Haiyun Wang, Yifu Song, Juanhan Yu, Di Zhang, Yang Jiang, Yuzhou Duan, Sheng Han

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Intracranial meningiomas are relatively rare in young adults, and their specific clinical features remain unclear. The authors analyzed the clinical characteristics of intracranial meningioma in patients younger than 40 years.

Methods

Consecutive patients younger than 40 years with meningioma (n = 223) who underwent surgical treatment at our hospital from 2010 to 2018 were retrospectively reviewed. The study cases was further divided into a younger group (≤ 30 years old; n = 63) and an older group (31–40 years old; n = 160). The clinical information, radiological characteristics, intraoperative findings, and pathological outcomes were extracted from the patients’ records and statistically analyzed.

Results

Intracranial meningioma is uncommon in patients younger than 40 years (8.6%). The study group’s most common symptoms at presentation were headaches (46.7%), visual impairment (27.8%), limb weakness (20.6%), and epilepsy (13.5%). The mean tumor size was larger (51.47 ± 50.36 cm³) in the younger group than in the older group (22.94 ± 27.20 cm³). According to multivariate analyses, young age was an independent predictor of large tumor size, and large tumor size was significantly associated with peritumoral brain edema and intraoperative blood loss.

Conclusion

Intracranial meningiomas in younger adult patients may have special complexity and perioperative risk due to large tumor sizes. Therefore, individualized treatment strategy is recommended, and the appropriate caution should be taken during surgery.

Nur mit Berechtigung zugänglich

Cushing H, Eisenhardt L (1938) Meningiomas: their classification, regional behavior, life history, and surgical end results. Charles C Thomas, Springfield

Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM (2005) Epidemiology of intracranial meningioma. Neurosurgery 57:1088–1095. https://doi.org/10.1227/01.Neu.0000188281.91351.B9 CrossRefPubMed

Baldi I, Engelhardt J, Bonnet C, Bauchet L, Berteaud E, Gruber A, Loiseau H (2018) Epidemiology of meningiomas. Neurochirurgie 64:5–14. https://doi.org/10.1016/j.neuchi.2014.05.006 CrossRefPubMed

Ravindranath K, Vasudevan MC, Pande A, Symss N (2013) Management of pediatric intracranial meningiomas: an analysis of 31 cases and review of literature. Child’s Nerv Syst 29:573–582. https://doi.org/10.1007/s00381-012-2010-7 CrossRef

Santos MV, Furlanetti L, Valera ET, Brassesco MS, Tone LG, de Oliveira RS (2012) Pediatric meningiomas: a single-center experience with 15 consecutive cases and review of the literature. Child’s Nerv Syst 28:1887–1896. https://doi.org/10.1007/s00381-012-1823-8 CrossRef

Gao X, Zhang R, Mao Y, Wang Y (2009) Childhood and juvenile meningiomas. Child’s Nerv Syst 25:1571–1580. https://doi.org/10.1007/s00381-009-0964-x CrossRef

Menon G, Nair S, Sudhir J, Rao BRM, Mathew A, Bahuleyan B (2009) Childhood and adolescent meningiomas: a report of 38 cases and review of literature. Acta Neurochir 151:239–244. https://doi.org/10.1007/s00701-009-0206-8 CrossRefPubMed

Arivazhagan A, Devi BI, Kolluri SV, Abraham RG, Sampath S, Chandramouli BA (2008) Pediatric intracranial meningiomas–do they differ from their counterparts in adults? Pediatr Neurosurg 44:43–48. https://doi.org/10.1159/000110661 CrossRefPubMed

Liu Y, Li F, Zhu S, Liu M, Wu C (2008) Clinical features and treatment of meningiomas in children: report of 12 cases and literature review. Pediatr Neurosurg 44:112–117. https://doi.org/10.1159/000113112 CrossRefPubMed

10.

Caroli E, Russillo M, Ferrante L (2006) Intracranial meningiomas in children: report of 27 new cases and critical analysis of 440 cases reported in the literature. J Child Neurol 21:31–36. https://doi.org/10.2310/7010.2006.00009 CrossRefPubMed

11.

Erdinçler P, Lena G, Sarioğlu AÇ, Kuday C, Choux M (1998) Intracranial meningiomas in children: review of 29 cases. Surg Neurol 49:136–140. https://doi.org/10.1016/s0090-3019(97)00343-1 CrossRefPubMed

12.

Bitzer M, Wöckel L, Luft AR, Wakhloo AK, Petersen D, Opitz H, Sievert T, Ernemann U, Voigt K (1997) The importance of pial blood supply to the development of peritumoral brain edema in meningiomas. J Neurosurg 87:368–373. https://doi.org/10.3171/jns.1997.87.3.0368 CrossRefPubMed

13.

Osawa T, Tosaka M, Nagaishi M, Yoshimoto Y (2013) Factors affecting peritumoral brain edema in meningioma: special histological subtypes with prominently extensive edema. J Neurooncol 111:49–57. https://doi.org/10.1007/s11060-012-0989-y CrossRefPubMed

14.

Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22–39CrossRefPubMedPubMedCentral

15.

Ferrante L, Acqui M, Artico M, Mastronardi L, Rocchi G, Fortuna A (1989) Cerebral meningiomas in children. Child’s Nerv Syst 5:83–86. https://doi.org/10.1007/bf00571115 CrossRef

16.

Germano IM, Edwards MSB, Davis RL, Schiffer D (1994) Intracranial meningiomas of the first two decades of life. J Neurosurg 80:447–453. https://doi.org/10.3171/jns.1994.80.3.0447 CrossRefPubMed

17.

Kotecha RS, Junckerstorff RC, Lee S, Cole CH, Gottardo NG (2011) Pediatric meningioma: current approaches and future direction. J Neuro-Oncol 104:1–10. https://doi.org/10.1007/s11060-010-0503-3 CrossRef

18.

Kotecha RS, Pascoe EM, Rushing EJ, Rorke-Adams LB, Zwerdling T, Gao X, Li X, Greene S, Amirjamshidi A, Kim S-K, Lima MA, Hung P-C, Lakhdar F, Mehta N, Liu Y, Devi BI, Sudhir BJ, Lund-Johansen M, Gjerris F, Cole CH, Gottardo NG (2011) Meningiomas in children and adolescents: a meta-analysis of individual patient data. Lancet Oncol 12:1229–1239. https://doi.org/10.1016/s1470-2045(11)70275-3 CrossRefPubMed

19.

Rushing EJ, Olsen C, Mena H, Rueda M-E, Lee Y-S, Keating RF, Santi M (2005) Central nervous system meningiomas in the first two decades of life: a clinicopathological analysis of 87 patients. J Neurosurg Pediatr 103:489–495. https://doi.org/10.3171/ped.2005.103.6.0489 CrossRef

20.

Wiedmann MKH, Brunborg C, Di Ieva A, Lindemann K, Johannesen TB, Vatten L, Helseth E, Zwart JA (2017) Overweight, obesity and height as risk factors for meningioma, glioma, pituitary adenoma and nerve sheath tumor: a large population-based prospective cohort study. Acta Oncol 56:1302–1309. https://doi.org/10.1080/0284186X.2017.1330554 CrossRefPubMed

21.

Niedermaier T, Behrens G, Schmid D, Schlecht I, Fischer B, Leitzmann MF (2015) Body mass index, physical activity, and risk of adult meningioma and glioma. Neurology 85:1342–1350. https://doi.org/10.1212/wnl.0000000000002020 CrossRefPubMed

22.

Zhang D, Chen J, Wang J, Gong S, Jin H, Sheng P, Qi X, Lv L, Dong Y, Hou L (2016) Body mass index and risk of brain tumors: a systematic review and dose-response meta-analysis. Eur J Clin Nutr 70:757–765. https://doi.org/10.1038/ejcn.2016.4 CrossRefPubMed

23.

Wiedmann M, Brunborg C, Lindemann K, Johannesen TB, Vatten L, Helseth E, Zwart JA (2013) Body mass index and the risk of meningioma, glioma and schwannoma in a large prospective cohort study (The HUNT Study). Br J Cancer 109:289–294. https://doi.org/10.1038/bjc.2013.304 CrossRefPubMedPubMedCentral

24.

Li X, Wang C, Lin Z, Zhao M, Ren X, Zhang X, Jiang Z (2019) Risk factors and control of seizures in 778 Chinese patients undergoing initial resection of supratentorial meningiomas. Neurosurg Rev. https://doi.org/10.1007/s10143-019-01085-5 CrossRefPubMedPubMedCentral

25.

Seyedi JF, Pedersen CB, Poulsen FR (2018) Risk of seizures before and after neurosurgical treatment of intracranial meningiomas. Clin Neurol Neurosurg 165:60–66. https://doi.org/10.1016/j.clineuro.2018.01.002 CrossRefPubMed

26.

Whittle IR, Smith C, Navoo P, Collie D (2004) Meningiomas. Lancet 363:1535–1543. https://doi.org/10.1016/s0140-6736(04)16153-9 CrossRefPubMed

27.

Riemenschneider MJ, Perry A, Reifenberger G (2006) Histological classification and molecular genetics of meningiomas. Lancet Neurol 5:1045–1054. https://doi.org/10.1016/s1474-4422(06)70625-1 CrossRefPubMed

28.

Guenther F, Swozil F, Heber S, Buchfelder M, Messlinger K, Fischer MJ (2018) Pre- and postoperative headache in patients with meningioma. Cephalalgia. https://doi.org/10.1177/0333102418793636 CrossRefPubMed

29.

Hou J, Kshettry VR, Selman WR, Bambakidis NC (2013) Peritumoral brain edema in intracranial meningiomas: the emergence of vascular endothelial growth factor-directed therapy. Neurosurg Focus 35:E2. https://doi.org/10.3171/2013.8.FOCUS13301 CrossRefPubMed

30.

Park KJ, Kang SH, Chae YS, Yu MO, Cho TH, Suh JK, Lee HK, Chung YG (2010) Influence of interleukin-6 on the development of peritumoral brain edema in meningiomas. J Neurosurg 112:73–80. https://doi.org/10.3171/2009.4.JNS09158 CrossRefPubMed

31.

Bitzer M, Wockel L, Morgalla M, Keller C, Friese S, Heiss E, Meyermann R, Grote E, Voigt K (1997) Peritumoural brain oedema in intracranial meningiomas: influence of tumour size, location and histology. Acta Neurochir 139:1136–1142. https://doi.org/10.1007/bf01410973 CrossRefPubMed

32.

Bitzer M, Opitz H, Popp J, Morgalla M, Gruber A, Heiss E, Voigt K (1998) Angiogenesis and brain oedema in intracranial meningiomas: influence of vascular endothelial growth factor. Acta Neurochir 140:333–340. https://doi.org/10.1007/s007010050106 CrossRefPubMed

33.

Inamura T, Nishio S, Takeshita I, Fujiwara S, Fukui M (1992) Peritumoral brain edema in meningiomas–influence of vascular supply on its development. Neurosurgery 31:179–185. https://doi.org/10.1227/00006123-199208000-00002 CrossRefPubMed

34.

Maiuri F, Gangemi M, Cirillo S, Delehaye L, Gallicchio B, Carandente M, Giamundo A (1987) Cerebral edema associated with meningiomas. Surg Neurol 27:64–68. https://doi.org/10.1016/0090-3019(87)90109-1 CrossRefPubMed

35.

Schmid S, Aboul-Enein F, Pfisterer W, Birkner T, Stadek C, Knosp E (2010) Vascular endothelial growth factor: the major factor for tumor neovascularization and edema formation in meningioma patients. Neurosurgery 67:1703–1708. https://doi.org/10.1227/NEU.0b013e3181fb801b CrossRefPubMed

36.

Gawlitza M, Fiedler E, Schob S, Hoffmann KT, Surov A (2017) Peritumoral brain edema in meningiomas depends on aquaporin-4 expression and not on tumor grade, tumor volume, cell count, or Ki-67 labeling index. Mol Imaging Biol 19:298–304. https://doi.org/10.1007/s11307-016-1000-7 CrossRefPubMed

37.

Lieu A-S, Howng S-L (1999) Intracranial meningiomas and epilepsy: incidence, prognosis and influencing factors. Epilepsy Res 38:45–52. https://doi.org/10.1016/s0920-1211(99)00066-2 CrossRef

38.

Vignes JR, Sesay M, Rezajooi K, Gimbert E, Liguoro D (2008) Peritumoral edema and prognosis in intracranial meningioma surgery. J Clin Neurosci 15:764–768. https://doi.org/10.1016/j.jocn.2007.06.001 CrossRefPubMed

39.

Alaywan M, Sindou M (1993) Prognostic factors in the surgery for intracranial meningioma. Role of the tumoral size and arterial vascularization originating from the pia mater. Study of 150 cases. Neurochirurgie 39:337–347PubMed

40.

Chun JY, McDermott MW, Lamborn KR, Wilson CB, Higashida R, Berger MS (2002) delayed surgical resection reduces intraoperative blood loss for embolized meningiomas. Neurosurgery 50:1231–1237. https://doi.org/10.1097/00006123-200206000-00010 CrossRefPubMed

41.

Lü J (2013) Correlation between preoperative imaging features and intraoperative blood loss of meningioma: a new scoring system for predicting intraoperative blood loss. J Neurosurg Sci 57:153–161PubMed

42.

Karsy M, Burnett B, Di Ieva A, Cusimano MD, Jensen RL (2018) Microvascularization of Grade I meningiomas: effect on tumor volume, blood loss, and patient outcome. J Neurosurg 128:657–666. https://doi.org/10.3171/2016.10.JNS161825 CrossRefPubMed

43.

Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, von Deimling A, Stavrinou P, Lefranc F, Lund-Johansen M, Moyal EC-J, Brandsma D, Henriksson R, Soffietti R, Weller M (2016) EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 17:e383–e391. https://doi.org/10.1016/s1470-2045(16)30321-7 CrossRefPubMed

44.

Berhouma M, Jacquesson T, Jouanneau E, Cotton F (2019) Pathogenesis of peri-tumoral edema in intracranial meningiomas. Neurosurg Rev. https://doi.org/10.1007/s10143-017-0897-x CrossRefPubMed

Titel: Comparative analysis of intracranial meningiomas in patients younger than 40 years
verfasst von: Tianhao Hu
Run Wang
Haiyun Wang
Yifu Song
Juanhan Yu
Di Zhang
Yang Jiang
Yuzhou Duan
Sheng Han
Publikationsdatum: 13.05.2019
Verlag: Springer US
Erschienen in: Journal of Neuro-Oncology / Ausgabe 3/2019
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-019-03191-2

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)

Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells

Triptolide reverses helper T cell inhibition and down-regulates IFN-γ induced PD-L1 expression in glioma cell lines

Health-related quality of life of patients with brain metastases selected for stereotactic radiosurgery

The case for radiosurgery for brainstem metastases